Allen Patricia L
SEC Form 4 insider trading activity
Allen Patricia L has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Feb 13, 2026.
On the most recent filing, Allen Patricia L is listed as Director at Zenas BioPharma, Inc. Inside the rolling window, Allen Patricia L reported 2 open-market purchases totaling $500K in ZBIO and no open-market sales. The largest disclosed transaction in the window is a purchase of 15,700 ZBIO shares on Feb 12, 2026, worth $390K.
Companies traded
Other insiders at ZBIO
Insider Buying
$500K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Allen Patricia L made?
Allen Patricia L has filed 1 SEC Form 4 filing (4 transaction rows) across 1 company since 2026.
Which companies does Allen Patricia L trade?
Allen Patricia L has filed SEC Form 4 disclosures for 1 company, including ZBIO.
When was Allen Patricia L's most recent SEC Form 4 filing?
Allen Patricia L's most recent SEC Form 4 filing on Tracefour is dated Feb 13, 2026.
What is Allen Patricia L's total buy and sell value in the current window?
Inside the rolling retention window, Allen Patricia L bought $500K and sold $0 based on SEC Form 4 filings.
What was Allen Patricia L's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 15,700 ZBIO shares on 2026-02-12, worth $390K, per SEC Form 4 filings.